myo-Inositol Uptake Is Essential for Bulk Inositol Phospholipid but Not Glycosylphosphatidylinositol Synthesis in Trypanosoma brucei

myo-Inositol is an essential precursor for the production of inositol phosphates and inositol phospholipids in all eukaryotes. Intracellular myo-inositol is generated by de novo synthesis from glucose 6-phosphate or is provided from the environment via myo-inositol symporters. We show that in Trypanosoma brucei, the causative pathogen of human African sleeping sickness and nagana in domestic animals, myo-inositol is taken up via a specific proton-coupled electrogenic symport and that this transport is essential for parasite survival in culture. Down-regulation of the myo-inositol transporter using RNA interference inhibited uptake of myo-inositol and blocked the synthesis of the myo-inositol-containing phospholipids, phosphatidylinositol and inositol phosphorylceramide; in contrast, it had no effect on glycosylphosphatidylinositol production. This together with the unexpected localization of the myo-inositol transporter in both the plasma membrane and the Golgi demonstrate that metabolism of endogenous and exogenous myo-inositol in T. brucei is strictly segregated. Background: Intracellular myo-inositol homeostasis involves both de novo synthesis and uptake of myo-inositol from the environment. Results: Down-regulation of the myo-inositol transporter in Trypanosoma brucei causes depletion of bulk inositol lipids, but not glycosylphosphatidylinositols, and leads to parasite death. Conclusion:De novo synthesis of myo-inositol is not sufficient to ensure bulk inositol lipid production. Significance:myo-Inositol metabolism in T. brucei is compartmentalized.